Skip to main content
Insights into Imaging
Fig. 3 | Insights into Imaging

Fig. 3

From: Factors affecting the value of diffusion-weighted imaging for identifying breast cancer patients with pathological complete response on neoadjuvant systemic therapy: a systematic review

Fig. 3

Studies reporting the percentage difference in ADC for pCR and non-pCR from baseline for the general study population at different time points. Note: The period of a cycle of neoadjuvant therapy (number of weeks) can differ within and between studies as well as the total number of cycles

Back to article page